It was observed that BBR treatment significantly decreased alanine-supplemented HCC cellular ATP content levels, while the overexpression of GPT1 reversed the decreased ATP content levels induced by BBR (Figure 6A). The gene discussed is GPT; the disease is hepatocellular carcinoma.